{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:05:28Z","timestamp":1761059128583},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.jss.2010.10.038","type":"journal-article","created":{"date-parts":[[2010,11,26]],"date-time":"2010-11-26T04:12:48Z","timestamp":1290744768000},"page":"365-369","source":"Crossref","is-referenced-by-count":4,"title":["Translating Cancer Genomes Sequencing Revolution into Surgical Oncology Practice"],"prefix":"10.1016","volume":"173","author":[{"given":"Christos","family":"Katsios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimosthenis E.","family":"Ziogas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Liakakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odysseas","family":"Zoras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios H.","family":"Roukos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2010.10.038_bib1","doi-asserted-by":"crossref","unstructured":"Roukos DH. Trastuzumab and beyond: Sequencing cancer genomes and predicting molecular networks Pharmacogenomics J 2010 Oct 26 [Epub ahead of print]. doi:10.1038\/tpj.2010.81.","DOI":"10.1038\/tpj.2010.81"},{"key":"10.1016\/j.jss.2010.10.038_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrc2656","article-title":"Novel anticancer targets: Revisiting ERBB2 and discovering ERBB3","volume":"9","author":"Baselga","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jss.2010.10.038_bib3","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMe058196","article-title":"Trastuzumab in the treatment of breast cancer","volume":"353","author":"Hortobagyi","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2010.10.038_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1634\/theoncologist.2008-0001","article-title":"Trastuzumab in the adjuvant treatment of early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Dahabreh","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.jss.2010.10.038_bib5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mdp322","article-title":"Thresholds for therapies:\u00a0Highlights of the St Gallen International Expert Consensus\u00a0on the primary therapy of early breast cancer 2009","volume":"20","author":"Goldhirsch","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2010.10.038_bib6","series-title":"Guidelines for treatment of cancer by site","year":"2009"},{"key":"10.1016\/j.jss.2010.10.038_bib7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2217\/pgs.10.104","article-title":"Complete genome sequencing and network modeling to overcome trastuzumab resistance","volume":"11","author":"Roukos","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jss.2010.10.038_bib8","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2010.10.038_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2010.10.038_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1245\/s10434-009-0766-0","article-title":"Targeting gastric cancer with trastuzumab: New clinical practice and innovative developments to overcome resistance","volume":"17","author":"Roukos","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2010.10.038_bib11","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer","volume":"360","author":"Van Cutsem","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jss.2010.10.038_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1586\/erm.10.49","article-title":"Genotype-phenotype map and molecular networks: A promising solution in overcoming colorectal cancer resistance to targeted treatment","volume":"10","author":"Roukos","year":"2010","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jss.2010.10.038_bib13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2010.10.038_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrclinonc.2010.97","article-title":"Understanding resistance to EGFR inhibitors-impact on future treatment strategies","volume":"7","author":"Wheeler","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jss.2010.10.038_bib15","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1200\/JCO.2008.20.0238","article-title":"Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer","volume":"27","author":"van Cutsem","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2010.10.038_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/458290a","article-title":"Cancer: The nuances of therapy","volume":"458","author":"Ellis","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1586\/era.09.116","article-title":"Current concerns and challenges towards tailored anti-angiogenic therapy in cancer","volume":"9","author":"Roukos","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jss.2010.10.038_bib18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/464649a","article-title":"The human genome at ten","volume":"464","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/464674a","article-title":"Has the revolution arrived?","volume":"464","author":"Collins","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/464676a","article-title":"Multiple personal genomes await","volume":"464","author":"Venter","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib21","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/nbt1486","article-title":"Next-generation DNA sequencing","volume":"26","author":"Shendure","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jss.2010.10.038_bib22","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/464670a","article-title":"The sequence explosion","volume":"464","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature08987","article-title":"International network of cancer genome projects","volume":"464","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nature08989","article-title":"Genome remodelling in a basal-like breast cancer metastasis and xenograft","volume":"464","author":"Ding\u200c","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nature09004","article-title":"The mutation spectrum revealed by paired genome sequences from a lung cancer patient","volume":"465","author":"Lee","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature08658","article-title":"A comprehensive catalogue of somatic mutations from a human cancer genome","volume":"463","author":"Pleasance","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib27","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/464972a","article-title":"Big science: The cancer genome challenge","volume":"464","author":"Ledford","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","article-title":"The cancer genome","volume":"458","author":"Stratton","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature07631","article-title":"Progress and challenges in genome-wide association studies in humans","volume":"456","author":"Donnelly","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra0905980","article-title":"Genomewide association studies and assessment of the risk of disease","volume":"363","author":"Manolio","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2010.10.038_bib31","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/466816a","article-title":"Which way for genetic-test regulation? Leave test interpretation to specialists","volume":"466","author":"Beaudet","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib32","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMp1006202","article-title":"Preparing for a consumer-driven genomic age","volume":"363","author":"Evans","year":"2010","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jss.2010.10.038_bib33","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp1006029","article-title":"Risks of presymptomatic direct-to-consumer genetic testing","author":"Annes","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2010.10.038_bib34","unstructured":"Food and Drug Administration. Medical devices. Letters to industry. Available at: http:\/\/www.fda.gov\/MedicalDevices\/ResourcesforYou\/Industry\/ucm111104.htm. Accessed August 2, 2010."},{"key":"10.1016\/j.jss.2010.10.038_bib35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/463587a","article-title":"Time for the epigenome","volume":"463","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib36","first-page":"799","article-title":"The ENCODE Project Consortium","volume":"447","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib37","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer","volume":"358","author":"Esteller","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2010.10.038_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/465145a","article-title":"Genomics goes beyond DNA sequence","volume":"465","author":"Katsnelson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature08454","article-title":"Molecular networks as sensors and drivers of common human diseases","volume":"461","author":"Schadt","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib40","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nature07633","article-title":"Reverse engineering the genotype\u2013phenotype map with natural genetic variation","volume":"456","author":"Rockman","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrc795","article-title":"Modelling the molecular circuitry of cancer","volume":"2","author":"Hahn","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jss.2010.10.038_bib42","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.1176495","article-title":"A global protein kinase and phosphatase interaction network in yeast","volume":"328","author":"Breitkreutz","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jss.2010.10.038_bib43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2217\/bmm.10.70","article-title":"Next-generation, genome sequencing-based biomarkers: Concerns and challenges for medical practice","volume":"4","author":"Roukos","year":"2010","journal-title":"Biomark Med"},{"key":"10.1016\/j.jss.2010.10.038_bib44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2217\/pme.10.30","article-title":"Individual genomes and personalized medicine: Life diversity and complexity","volume":"7","author":"Katsios","year":"2010","journal-title":"Per Med"},{"key":"10.1016\/j.jss.2010.10.038_bib45","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1126\/science.1171297","article-title":"Mathematics. Emergence of connectivity in networks","volume":"323","author":"Bohman","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jss.2010.10.038_bib46","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nature09319","article-title":"Statistical inference for noisy nonlinear ecological dynamic systems","volume":"466","author":"Wood","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jss.2010.10.038_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/erm.09.69","article-title":"Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care","volume":"10","author":"Roukos","year":"2010","journal-title":"Expert Rev Mol Diagn"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480410009182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480410009182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T11:26:56Z","timestamp":1559820416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480410009182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0022480410009182"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2010.10.038","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}